The core database

Longevity drugs, graded.

Every compound people ask about — what it does, what the human evidence actually shows, and how people access it. Conservative by design.

Evidence

12 of 12 entries · select up to 3 to compare

mTORGRADE C

Rapamycin

Sirolimus

The most-studied lifespan-extending compound in animals; human longevity data still emerging.

Status
Rx
Typical cost
$30–$150 / mo
metabolicGRADE B

Metformin

Decades-old diabetes drug studied for healthy aging; strong safety record, unproven for longevity in non-diabetics.

Status
Rx
Typical cost
$5–$20 / mo
metabolicGRADE C

Acarbose

A carb-blocking diabetes drug that robustly extends lifespan in male mice.

Status
Rx
Typical cost
$20–$60 / mo
GLP-1GRADE A

Semaglutide

Ozempic / Wegovy

GLP-1 agonist with hard-outcome RCT data: weight loss and reduced cardiovascular events.

Status
Rx
Typical cost
$200–$1,300 / mo
GLP-1GRADE A

Tirzepatide

Mounjaro / Zepbound

Dual GIP/GLP-1 agonist producing the largest average weight loss of any approved drug.

Status
Rx
Typical cost
$400–$1,200 / mo
metabolicGRADE A

SGLT2 inhibitors

Empagliflozin (Jardiance)

Glucose-lowering drugs with strong heart and kidney outcome data, even outside diabetes.

Status
Rx
Typical cost
$30–$600 / mo
NAD+/mitochondrialGRADE C

NAD+ / NMN

Nicotinamide mononucleotide, NR

Precursors that reliably raise blood NAD+; meaningful human health benefits remain unproven.

Status
Supplement
Typical cost
$40–$150 / mo
otherGRADE C

Low-dose naltrexone

LDN

Tiny doses of an addiction drug, studied for chronic pain and inflammation.

Status
Rx / compounded
Typical cost
$25–$60 / mo
otherGRADE D

Taurine

An amino acid that declines with age; extended lifespan in mice, human trials pending.

Status
Supplement
Typical cost
$10–$25 / mo
otherGRADE D

Spermidine

A dietary polyamine that induces autophagy; human evidence is observational.

Status
Supplement
Typical cost
$30–$70 / mo

Not medical advice — talk to a licensed clinician. Content is educational, reflects published literature, and is not a recommendation to start, stop or change any treatment.